CDK7 overexpression is associated with poor survival in patients with gastric cancer, whereas CDK7 inhibition decreases the proliferation in a gastric cancer cell line, suggesting CDK7 as a potential therapeutic target50. Here, CDK7 is linked to gastric cancer.